Evogene (EVGN)
0.54
-0.01 (1.82%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13D/A Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
August 28, 2026 9:21 AM - SEC Filing
Form 6-K Evogene Ltd. For: Aug 27
August 27, 2026 8:30 AM - SEC Filing
EverGen Infrastructure Reports Q2 2026 Results
August 27, 2026 12:26 AM - BizWire
EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026
August 26, 2026 5:00 PM - BizWire
Form 4 Evogene Ltd. For: Jun 04 Filed by: Tarcic Gabi
August 26, 2026 4:01 PM - SEC Filing
ISS and Glass Lewis back Evogene board nominees ahead of AGM
August 25, 2026 7:00 AM - StreetInsider
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
August 25, 2026 7:00 AM - PR NewsWire
Evogene Reports Second Quarter and First Half 2026 Financial Results
August 18, 2026 8:04 AM - PR NewsWire
Evogene (EVGN) Tops Q2 EPS by 15c
August 18, 2026 7:10 AM - StreetInsider
Form 6-K Evogene Ltd. For: Aug 18
August 18, 2026 7:01 AM - SEC Filing
Form SCHEDULE 13G/A Evogene Ltd. Filed by: ARMISTICE CAPITAL, LLC
August 14, 2026 10:13 AM - SEC Filing
Evogene chairman to address dissident shareholders on results call
August 14, 2026 7:00 AM - StreetInsider
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
August 14, 2026 7:00 AM - PR NewsWire
Form SCHEDULE 13D/A Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
August 13, 2026 2:39 PM - SEC Filing
Form SCHEDULE 13D/A Evogene Ltd. Filed by: RECANATI LEON
August 13, 2026 7:06 AM - SEC Filing
Form 4 Evogene Ltd. For: Aug 11 Filed by: RECANATI LEON
August 13, 2026 7:00 AM - SEC Filing
Form SCHEDULE 13D Evogene Ltd. Filed by: RECANATI LEON
August 11, 2026 8:00 AM - SEC Filing
Form SCHEDULE 13D/A Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
August 7, 2026 4:06 PM - SEC Filing
Form 4 Evogene Ltd. For: Aug 04 Filed by: RECANATI LEON
August 5, 2026 4:08 PM - SEC Filing
Form 6-K Evogene Ltd. For: Jul 31
July 31, 2026 4:02 PM - SEC Filing
Evogene Schedules Second Quarter 2026 Financial Results Release
July 30, 2026 7:00 AM - PR NewsWire
Form SCHEDULE 13D/A Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
July 27, 2026 7:23 AM - SEC Filing
Evogene and ELEO team up on oral PCSK9 inhibitor discovery
July 22, 2026 8:02 AM - StreetInsider
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
July 22, 2026 8:00 AM - PR NewsWire
Form SCHEDULE 13D/A Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
July 20, 2026 3:47 PM - SEC Filing
Form 424B5 Evogene Ltd.
July 17, 2026 4:06 PM - SEC Filing
Form 6-K Evogene Ltd. For: Jul 17
July 17, 2026 4:03 PM - SEC Filing
AgPlenus launches AI model to predict antifungal potency
July 15, 2026 7:31 AM - StreetInsider
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
July 15, 2026 7:30 AM - PR NewsWire
EverGen Infrastructure Announces Record RNG Production for Q2 2026
July 14, 2026 4:05 PM - BizWire
Form SCHEDULE 13D Evogene Ltd. Filed by: L.I.A. Pure Capital Ltd
July 10, 2026 9:27 AM - SEC Filing
Evogene and Tel Aviv University partner on AI drug discovery
July 8, 2026 7:01 AM - StreetInsider
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
July 8, 2026 7:00 AM - PR NewsWire
EverGen Infrastructure Announces Share Issuance to Officers and Directors of the Company
July 6, 2026 11:00 PM - BizWire
Evogene integrates Google Cloud AI agents into its ChemPass platform
June 24, 2026 8:01 AM - StreetInsider
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization
June 24, 2026 8:00 AM - PR NewsWire
Form 6-K Evogene Ltd. For: Jun 16
June 16, 2026 7:00 AM - SEC Filing
Form 424B5 Evogene Ltd.
June 11, 2026 4:06 PM - SEC Filing
Form 6-K Evogene Ltd. For: Jun 11
June 11, 2026 4:01 PM - SEC Filing
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
June 9, 2026 7:00 AM - PR NewsWire
Full Article List
